Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongling Zou

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Ovarian Research|June 27, 2023
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world studyXingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
Journal of Ovarian Research|February 18, 2025
The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world studyXingyu Liu, Ming Li, Yingjun Zhao, et al.
Journal of Ovarian Research|April 29, 2025
The impact of preoperative immunonutritional status on postoperative complications in ovarian cancerXingyu Liu, Ming Li, Yingjun Zhao, et al.
Haematologica|April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmCChenying Li, Lei Dong, Rui Su, et al.
Nature Cell Biology|August 4, 2022
METTL3 preferentially enhances non-m<sup>6</sup>A translation of epigenetic factors and promotes tumourigenesisXueju Wei, Yue Huo, Jingnan Pi, et al.
The Lancet. Oncology|December 4, 2023
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trialKezhen Li, Jing Chen, Yingjie Hu, et al.
The Lancet. Oncology|June 3, 2023
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registryTian Chu, Yifan Meng, Ping Wu, et al.
Cell|December 19, 2017
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m<sup>6</sup>A/MYC/CEBPA SignalingRui Su, Lei Dong, Chenying Li, et al.
JAMA Oncology|July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical TrialNing Li, Jianqing Zhu, Rutie Yin, et al.
Cell Genomics|February 13, 2023
Multi-omics characterization of silent and productive HPV integration in cervical cancerJunpeng Fan, Yu Fu, Wenju Peng, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Ovarian Research|June 27, 2023
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world studyXingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
Journal of Ovarian Research|February 18, 2025
The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world studyXingyu Liu, Ming Li, Yingjun Zhao, et al.
Journal of Ovarian Research|April 29, 2025
The impact of preoperative immunonutritional status on postoperative complications in ovarian cancerXingyu Liu, Ming Li, Yingjun Zhao, et al.
Haematologica|April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmCChenying Li, Lei Dong, Rui Su, et al.
Nature Cell Biology|August 4, 2022
METTL3 preferentially enhances non-m<sup>6</sup>A translation of epigenetic factors and promotes tumourigenesisXueju Wei, Yue Huo, Jingnan Pi, et al.
The Lancet. Oncology|December 4, 2023
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trialKezhen Li, Jing Chen, Yingjie Hu, et al.
The Lancet. Oncology|June 3, 2023
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registryTian Chu, Yifan Meng, Ping Wu, et al.
Cell|December 19, 2017
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m<sup>6</sup>A/MYC/CEBPA SignalingRui Su, Lei Dong, Chenying Li, et al.
JAMA Oncology|July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical TrialNing Li, Jianqing Zhu, Rutie Yin, et al.
Cell Genomics|February 13, 2023
Multi-omics characterization of silent and productive HPV integration in cervical cancerJunpeng Fan, Yu Fu, Wenju Peng, et al.
Pageof 7